Found: 98
Select item for more details and to access through your institution.
DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome—including in elderly patients.
- Published in:
- Acta Neuropathologica Communications, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40478-022-01344-5
- By:
- Publication type:
- Article
Gliome - was ich wissen muss in zehn Fragen.
- Published in:
- Praxis (16618157), 2016, v. 105, n. 6, p. 330, doi. 10.1024/1661-8157/a002303
- By:
- Publication type:
- Article
De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Corticosteroids compromise survival in glioblastoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Tumor type, epilepsy burden, and seizure documentation: experiences at a single center neuro-oncology clinic.
- Published in:
- Neuro-Oncology Practice, 2021, v. 8, n. 5, p. 581, doi. 10.1093/nop/npab032
- By:
- Publication type:
- Article
Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients.
- Published in:
- Neuro-Oncology Practice, 2020, v. 7, n. 6, p. 668, doi. 10.1093/nop/npaa033
- By:
- Publication type:
- Article
MGMT methylation status: The advent of stratified therapy in glioblastoma?
- Published in:
- Disease Markers, 2007, v. 23, n. 1-2, p. 97, doi. 10.1155/2007/159242
- By:
- Publication type:
- Article
Targeting brain-tumor stem cells.
- Published in:
- Nature Biotechnology, 2007, v. 25, n. 2, p. 193, doi. 10.1038/nbt0207-193
- By:
- Publication type:
- Article
Will integrin inhibitors have proangiogenic effects in the clinic?
- Published in:
- 2009
- By:
- Publication type:
- Letter
Experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigue.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacious and save use of biosimilar filgrastim for hematopoietic progenitor cell chemo-mobilization with vinorelbine in multiple myeloma patients.
- Published in:
- Journal of Clinical Apheresis, 2017, v. 32, n. 1, p. 21, doi. 10.1002/jca.21459
- By:
- Publication type:
- Article
Repeated blood–brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45818-7
- By:
- Publication type:
- Article
Modulation of Angiogenic and Inflammatory Response in Glioblastoma by Hypoxia.
- Published in:
- PLoS ONE, 2009, v. 4, n. 6, p. 1, doi. 10.1371/journal.pone.0005947
- By:
- Publication type:
- Article
Correlative studies in neuro-oncology trials: Should they influence treatment?
- Published in:
- Current Oncology Reports, 2006, v. 8, n. 1, p. 54, doi. 10.1007/s11912-006-0010-z
- By:
- Publication type:
- Article
Clinical Implications of Molecular Neuropathology and Biomarkers for Malignant Glioma.
- Published in:
- Current Neurology & Neuroscience Reports, 2012, v. 12, n. 3, p. 302, doi. 10.1007/s11910-012-0263-x
- By:
- Publication type:
- Article
Optimal role of temozolomide in the treatment of malignant gliomas.
- Published in:
- Current Neurology & Neuroscience Reports, 2005, v. 5, n. 3, p. 198, doi. 10.1007/s11910-005-0047-7
- By:
- Publication type:
- Article
B cell-rich non-neoplastic sentinel lesion preceding primary central nervous system lymphoma.
- Published in:
- Diagnostic Pathology, 2018, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13000-018-0717-9
- By:
- Publication type:
- Article
A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physicians.
- Published in:
- BMC Cancer, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s12885-024-12042-x
- By:
- Publication type:
- Article
Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Development of OXY111A, a novel hypoxiamodifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial.
- Published in:
- BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2855-3
- By:
- Publication type:
- Article
Newly Diagnosed Glioblastoma: A Review on Clinical Management.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 3, p. 91
- By:
- Publication type:
- Article
Primary Central Nervous System Lymphoma Part 2: Modern therapeutic Management and Future Directions.
- Published in:
- Oncology (08909091), 2018, v. 32, n. 2, p. e11
- By:
- Publication type:
- Article
Primary Central Nervous System Lymphoma: PART 1: Epidemiology, Diagnosis, Staging, and Prognosis.
- Published in:
- Oncology (08909091), 2018, v. 32, n. 1, p. 17
- By:
- Publication type:
- Article
Combined modality treatment with full-dose chemotherapy and concomitant boost radiotherapy for advanced head and neck carcinoma.
- Published in:
- European Archives of Oto-Rhino-Laryngology, 2005, v. 262, n. 1, p. 1, doi. 10.1007/s00405-003-0725-5
- By:
- Publication type:
- Article
Ipilimumab and early signs of pulmonary toxicity in patients with metastastic melanoma: a prospective observational study.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 127, doi. 10.1007/s00262-017-2071-2
- By:
- Publication type:
- Article
Building Team Medicine in the Management of CNS Metastases.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 12, p. 3901, doi. 10.3390/jcm12123901
- By:
- Publication type:
- Article
Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5494, doi. 10.3390/cancers14225494
- By:
- Publication type:
- Article
Are Integrins Still Practicable Targets for Anti-Cancer Therapy?
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 978, doi. 10.3390/cancers11070978
- By:
- Publication type:
- Article
Developing an Integrative Treatment Program for Cancer-Related Fatigue Using Stakeholder Engagement – A Qualitative Study.
- Published in:
- Integrative Cancer Therapies, 2018, v. 17, n. 3, p. 762, doi. 10.1177/1534735417740629
- By:
- Publication type:
- Article
Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation results.
- Published in:
- Acta Neuropathologica Communications, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40478-023-01680-0
- By:
- Publication type:
- Article
Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 22, p. 8373, doi. 10.1002/cam4.3447
- By:
- Publication type:
- Article
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 8, p. 1327, doi. 10.1093/neuonc/noab037
- By:
- Publication type:
- Article
MGMT promoter methylation is associated with patient age and 1p/19q status in IDH-mutant gliomas.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 5, p. 858, doi. 10.1093/neuonc/noab039
- By:
- Publication type:
- Article
Memory in low-grade glioma patients treated with radiotherapy or temozolomide: a correlative analysis of EORTC study 22033-26033.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 5, p. 803, doi. 10.1093/neuonc/noaa252
- By:
- Publication type:
- Article
Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 470, doi. 10.1093/neuonc/noz216
- By:
- Publication type:
- Article
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 12, p. 1498, doi. 10.1093/neuonc/noz119
- By:
- Publication type:
- Article
Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 11, p. 1447, doi. 10.1093/neuonc/noz118
- By:
- Publication type:
- Article
MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 167, doi. 10.1093/neuonc/noy132
- By:
- Publication type:
- Article
QOLP-11. QUALITY OF LIFE IN HIGH-GRADE GLIOMA PATIENTS ON A PHASE I VIROTHERAPY STUDY.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi216, doi. 10.1093/neuonc/noy148.897
- By:
- Publication type:
- Article
CSIG-18. MODELING TEMOZOLOMIDE RESISTANCE WITH GLIOBLASTOMA PATIENT DERIVED XENOGRAFTS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi46, doi. 10.1093/neuonc/noy148.184
- By:
- Publication type:
- Article
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 5, p. 625, doi. 10.1093/neuonc/nox029
- By:
- Publication type:
- Article
Tumor treating fields: a novel treatment modality and its use in brain tumors.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 10, p. 1338, doi. 10.1093/neuonc/now182
- By:
- Publication type:
- Article
Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma?
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 11, p. 1425, doi. 10.1093/neuonc/nov198
- By:
- Publication type:
- Article
GENETIC AND EPIGENETIC DEREGULATION ARE ASSOCIATED WITH THE ABERRANT EXPRESSION OF A STEM CELL RELATED HOX GENE SIGNATURE IN GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii8, doi. 10.1093/neuonc/nou206.26
- By:
- Publication type:
- Article
Questions regarding the optimal use of bevacizumab in glioblastoma: a moving target.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 6, p. 765, doi. 10.1093/neuonc/nou092
- By:
- Publication type:
- Article
Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 4, p. 584, doi. 10.1093/neuonc/not170
- By:
- Publication type:
- Article
New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 11, p. 1568, doi. 10.1093/neuonc/not117
- By:
- Publication type:
- Article
EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 12, p. 1503, doi. 10.1093/neuonc/nos256
- By:
- Publication type:
- Article
Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. suppl_4, p. iv100, doi. 10.1093/neuonc/nos206
- By:
- Publication type:
- Article